New pill shows promise in treating cannabis addiction.

An experimental pill called AEF0117 has shown promising results in reducing the positive effects of cannabis by up to 38% in initial trials. The drug, derived from pregnenolone, inhibits the CB1 receptors responsible for the addictive effects of cannabis and appears to counteract the "high". Cannabis use disorder affects up to 30% of weed users, and there are currently no drugs to treat it. The findings will need to be replicated in larger trials, but the initial results are encouraging.